La catarata de información sobre la inscripción a Medicare no explica bien las opciones de Medigap
En parte porque las políticas sobre el acceso y los costos de Medigap cambian dependiendo del estado, o por la información confusa, muchos beneficiarios no eligen lo que más les conviene.
Medicare Enrollment Blitz Doesn’t Include Options to Move Into Medigap
TV ads and mailings targeting seniors tout Medicare Advantage plans this time of year, but millions choosing traditional Medicare make a costly and difficult decision about Medigap coverage, which gets much less attention.
Though Millions Are at Risk for Diabetes, Medicare Struggles to Expand Prevention Program
Medicare has proposed revamping its payment rules to get more people into a diabetes prevention plan that helps them eat better, exercise more and maintain a healthier lifestyle. Out of an estimated 16 million Medicare beneficiaries whose excess weight and other risk factors make them eligible, only 3,600 have participated since 2018.
Federal Speech Rulings May Embolden Health Care Workers to Call Out Safety Issues
Policies mandating company approval before talking publicly about conditions in hospitals have been a source of conflict over the past year, as physicians, nurses and other health workers have been disciplined for speaking or posting about what they view as dangerous covid-19 safety precautions. The appeals court’s decision could mean that hospitals — and other employers — will need to revise their policies.
FDA Weighs Approval of a Lucrative Alzheimer’s Drug, but Benefits Are Iffy
The agency is to decide by June 7 whether to greenlight Biogen’s drug aducanumab, despite a near-unanimous rejection of the product by an FDA advisory committee of outside experts in November. Some scientists at the agency have endorsed the drug, though.
Big Investors Push Nursing Homes to Upgrade Care and Working Conditions
Responsible for 34% of the nation’s covid death toll, nursing homes and long-term care facilities get slammed by their investors and are told to change.
FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar
A misguided federal program called the Unapproved Drugs Initiative, which put the FDA’s stamp of approval on old drugs, led to higher prices. It’s scrapped. So now what?
Families With Sick Kids on Medicaid Seek Easier Access to Out-of-State Hospitals
Many state Medicaid programs pay out-of-state providers much less than in-state facilities, often making it hard for families with medically complex children to get the care they seek.
‘Incredibly Concerning’ Lawsuit Threatens No-Charge Preventive Care for Millions
A Texas federal judge, who previously ruled the Affordable Care Act unconstitutional, has signaled his openness to ending the law’s popular coverage requirement for preventive services.
Doctors Debate Use of Blood Thinners to Prevent Clots in Women After C-Sections
One group of maternal health experts in 2016 urged doctors to give all women heparin shots after C-sections, barring specific medical risks for individual patients. But many physicians disagree, questioning whether wide use of the drug is effective, worth the cost and safe, since it carries the risk of bleeding.
As Drug Prices Keep Rising, State Lawmakers Propose Tough New Bills to Curb Them
The measures would impose taxes on increases in the price of drugs that don’t reflect improved clinical value and set the rates paid by state-run and commercial health plans to a benchmark based on prices in Canada.
An Urban Hospital on the Brink Vs. the Officials Sworn to Save It
The wealthy corporation that owns Chicago’s Mercy Hospital says it must close the hospital because it’s losing money. A government board says no. The corporation still has the upper hand.
Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets
While many private insurers cap what members pay in health costs, Medicare does not. Democrats and Republicans in Congress have proposed annual limits ranging from $2,000 to $3,100. But there’s disagreement about how to pay for that cost cap.
Surprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription Drugs
A provision the Trump administration tucked into its final rule on health plan price transparency requires telling consumers what they will pay out-of-pocket for drugs and showing them what the plan paid.
A $200 Debit Card Won’t Do Much for Seniors’ Drug Costs
President Donald Trump wants to send seniors $200 apiece. Beyond the legal and logistical problems, health care experts point out it does little to help someone with even typical prescription costs.
COVID Data Failures Create Pressure for Public Health System Overhaul
Poor information-sharing between hospitals and public health agencies has hurt the response to the pandemic. Some health care systems and IT companies are making inroads, but an overhaul would cost billions.
Hospital Merger in Washington State Stokes Fears About Catholic Limits on Care
Virginia Mason Health System and CHI Franciscan announced plans in July to merge 12 hospitals and more than 250 other treatment sites in the Puget Sound region and the Yakima area. Some patient advocacy groups warn the proposal would jeopardize access to needed services, such as emergency termination of pregnancies, contraception and physician aid in dying.
Employers Require COVID Liability Waivers as Conflict Mounts Over Workplace Safety
While Congress negotiates liability protection for reopening businesses as part of its latest pandemic bailout package, some employers are already requiring workers to sign waivers agreeing not to sue if they get COVID-19 on the job.
Group Health Teams With Hospital System In Pacific Northwest
The joint venture seeks to coordinate patient care and cut costs for employers and health plans.
Wash. State Insurer, Official Clash Over Drug Coverage Cutbacks
A fight between the Washington State insurance commissioner and the state’s largest seller of individual health insurance is spotlighting problems in that increasingly troubled market. The spat arose over insurers’ efforts to curb soaring premiums by restricting or eliminating prescription drug benefits. Experts say they haven’t yet seen similar moves by insurers in other states to […]